Here are five stocks added to the Zacks Rank #1 (Strong Buy) List today:
Artivion, Inc. AORT: This medical device and tissue engineering company has seen the Zacks Consensus Estimate for its current year earnings increasing 68.2% over the last 60 days.
Artivion, Inc. Price and Consensus
Artivion, Inc. price-consensus-chart | Artivion, Inc. Quote
Vertex, Inc. VERX: This tax technology solutions provider has seen the Zacks Consensus Estimate for its current year earnings increasing 8.6% over the last 60 days.
Vertex, Inc. Price and Consensus
Vertex, Inc. price-consensus-chart | Vertex, Inc. Quote
NextNav Inc. NN: This positioning, navigation, and timing (PNT) solutions provider has seen the Zacks Consensus Estimate for its current year earnings increasing 7.5% over the last 60 days.
NextNav Inc. Price and Consensus
NextNav Inc. price-consensus-chart | NextNav Inc. Quote
Immunocore Holdings plc IMCR: This biotechnology company has seen the Zacks Consensus Estimate for its current year earnings increasing 48.6% over the last 60 days.
Immunocore Holdings PLC Sponsored ADR Price and Consensus
Immunocore Holdings PLC Sponsored ADR price-consensus-chart | Immunocore Holdings PLC Sponsored ADR Quote
EverQuote, Inc. EVER: This online marketplace company has seen the Zacks Consensus Estimate for its current year earnings increasing 19.7% over the last 60 days.
EverQuote, Inc. Price and Consensus
EverQuote, Inc. price-consensus-chart | EverQuote, Inc. Quote
You can see the complete list of today’s Zacks #1 Rank (Strong Buy) stocks here.
5 Stocks Set to Double
Each was handpicked by a Zacks expert as the #1 favorite stock to gain +100% or more in 2024. While not all picks can be winners, previous recommendations have soared +143.0%, +175.9%, +498.3% and +673.0%.
Most of the stocks in this report are flying under Wall Street radar, which provides a great opportunity to get in on the ground floor.
Today, See These 5 Potential Home Runs >>EverQuote, Inc. (EVER) : Free Stock Analysis Report
Vertex, Inc. (VERX) : Free Stock Analysis Report
Immunocore Holdings PLC Sponsored ADR (IMCR) : Free Stock Analysis Report
NextNav Inc. (NN) : Free Stock Analysis Report
Artivion, Inc. (AORT) : Free Stock Analysis Report
To read this article on Zacks.com click here.
The views and opinions expressed herein are the views and opinions of the author and do not necessarily reflect those of Nasdaq, Inc.
